Suppr超能文献

塞浦路斯共和国一家重症监护病房收治的首批19例2019新型冠状病毒肺炎患者的临床特征、治疗及转归

Clinical Characteristics, Management, and Outcome of the First 19 Patients With Pneumonia Due to the 2019 Novel Coronavirus Disease Treated in an Intensive Care Unit in the Republic of Cyprus.

作者信息

Kastoris Antonia, Iordanou Stelios, Efseviou Christos, Papastylianou Andry, Soteriades Elpidoforos S, Palazis Lakis

机构信息

Intensive Care Unit, Nicosia General Hospital, Nicosia, CYP.

Intensive Care Unit, Limassol General Hospital, Limassol, CYP.

出版信息

Cureus. 2021 May 19;13(5):e15114. doi: 10.7759/cureus.15114.

Abstract

Background The widespread reach of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its consequences have severely affected the consistency of healthcare systems around the world and caused millions of deaths to date. Understanding the coronavirus disease 2019 (COVID-19) manifestation, progression, and management is crucial for the healthcare personnel caring for COVID-19 patients within the intensive care unit (ICU), as well as for the patients' health progression. Methods A prospective observational study was used to investigate the progression of critically ill COVID-19 positive patients who were admitted to the ICU of Nicosia General Hospital from March 10 to May 1, 2020. All patients over the age of 18 were included in the study; their data were anonymously collected using the institution's electronic medical record system and analyzed in Microsoft Excel (Microsoft Corporation, Redmond, WA). Pregnant women, children, and prisoners were excluded. Results During the study period, a total of 19 patients with a positive result on a reverse-transcriptase polymerase chain reaction (RT-PCR) were included in the study; 74% were men and their mean age was 64 years. Sixty-three percent of the patients were obese, 53% had a history of confirmed hypertension, 68% were admitted with severe respiratory failure, and all of them required invasive mechanical ventilation. Patients were categorized into four groups of ventilation based on the H or L ventilation phenotype in association with co-morbidities. Prone position in the first mechanical ventilation days was found to be more advantageous in L than H phenotype patients, 68% required vasopressor support, and 42% developed acute kidney injury (AKI) during their ICU stay. Diarrhea was with a median day of onset of eight days. Lactate levels above 2 mmol/L in the first four days of admission were correlated with a negative outcome. Nine patients (47%) were successfully discharged from the ICU while 10 (53%) died during their stay. Conclusion In critically ill patients, male gender and obesity are significant risk factors for ICU admission due to COVID-19, and early prone position, mechanical ventilation, and low positive end-expiratory pressures (PEEP) values may be beneficial, especially in the L phenotype category patients. Patients' ventilation phenotype during ICU admission and hospitalization seemed to determine the outcome. Clinical improvement might have been higher and possibly ICU mortality lower if remdesivir was available. Hydroxychloroquine did not seem to improve patient outcomes, a consistent find, as suggested by other studies; on the contrary, it may have contributed to increased mortality rates.

摘要

背景 严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的广泛传播及其后果严重影响了世界各地医疗系统的稳定性,迄今为止已导致数百万人死亡。了解2019冠状病毒病(COVID-19)的表现、进展和治疗方法,对于在重症监护病房(ICU)护理COVID-19患者的医护人员以及患者的健康进展至关重要。方法 采用前瞻性观察性研究,调查2020年3月10日至5月1日入住尼科西亚综合医院ICU的COVID-19重症阳性患者的病情进展。所有18岁以上的患者均纳入研究;使用该机构的电子病历系统匿名收集他们的数据,并在Microsoft Excel(微软公司,华盛顿州雷德蒙德)中进行分析。孕妇、儿童和囚犯被排除在外。结果 在研究期间,共有19例逆转录酶聚合酶链反应(RT-PCR)结果呈阳性的患者纳入研究;74%为男性,平均年龄为64岁。63%的患者肥胖,53%有确诊高血压病史,68%因严重呼吸衰竭入院,所有患者均需要有创机械通气。根据H或L通气表型及合并症将患者分为四组通气类型。发现在机械通气的头几天,俯卧位对L表型患者比H表型患者更有利,68%的患者需要血管活性药物支持,42%的患者在ICU住院期间发生急性肾损伤(AKI)。腹泻的中位发病时间为8天。入院前四天乳酸水平高于2 mmol/L与不良预后相关。9名患者(47%)成功从ICU出院,10名患者(53%)在住院期间死亡。结论 在重症患者中,男性和肥胖是因COVID-19入住ICU的重要危险因素,早期俯卧位、机械通气和低呼气末正压(PEEP)值可能有益,尤其是在L表型患者中。患者在ICU入院和住院期间的通气表型似乎决定了预后。如果有瑞德西韦,临床改善可能会更高,ICU死亡率可能会更低。羟氯喹啉似乎并未改善患者预后,正如其他研究所表明的那样,这是一个一致的发现;相反,它可能导致了死亡率的上升。

相似文献

2
Clinical characteristics and outcomes of critically ill patients with COVID-19 in a tertiary community hospital in upstate New York.
J Community Hosp Intern Med Perspect. 2020 Oct 29;10(6):491-500. doi: 10.1080/20009666.2020.1811070.
9
Long-term survival of mechanically ventilated patients with severe COVID-19: an observational cohort study.
Ann Intensive Care. 2021 Oct 2;11(1):143. doi: 10.1186/s13613-021-00929-y.

本文引用的文献

2
ESICM LIVES 2020.
Intensive Care Med Exp. 2020 Dec 14;8(Suppl 2):73. doi: 10.1186/s40635-020-00354-8.
3
Racial and Gender-Based Differences in COVID-19.
Front Public Health. 2020 Jul 28;8:418. doi: 10.3389/fpubh.2020.00418. eCollection 2020.
4
Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
Expert Rev Anti Infect Ther. 2021 Jan;19(1):5-16. doi: 10.1080/14787210.2020.1799785. Epub 2020 Aug 16.
5
Putative Mechanisms of Diarrhea in COVID-19.
Clin Gastroenterol Hepatol. 2020 Dec;18(13):3054-3055. doi: 10.1016/j.cgh.2020.06.008. Epub 2020 Jun 12.
6
Effective treatment of severe COVID-19 patients with tocilizumab.
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
7
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan.
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):534-535. doi: 10.1016/S2468-1253(20)30118-7. Epub 2020 Apr 15.
8
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
9
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
10
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验